Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Extracellular vesicles (EVs) from stem cells, developed by the Vinmec Center for Stem Cells and Gene Technology, represent a cell-free regenerative medicine platform. These vesicles, including exosomes and microvesicles, are nano-sized membrane-bound particles secreted by stem cells that carry a complex cargo of signaling molecules such as microRNAs, growth factors, and lipids. By delivering these mediators to recipient cells, EVs mimic the paracrine effects of stem cells, promoting tissue repair, immunomodulation, and skin rejuvenation without the risks associated with live cell transplantation. The program is currently in preclinical development, targeting aesthetic applications and a variety of degenerative or inflammatory diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on extracellular vesicles from stem cells.